GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » VWR Corp (NAS:VWR) » Definitions » Debt-to-EBITDA

VWR (VWR) Debt-to-EBITDA : 4.23 (As of Sep. 2017)


View and export this data going back to 2014. Start your Free Trial

What is VWR Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

VWR's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2017 was $320 Mil. VWR's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2017 was $1,860 Mil. VWR's annualized EBITDA for the quarter that ended in Sep. 2017 was $516 Mil. VWR's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2017 was 4.22.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for VWR's Debt-to-EBITDA or its related term are showing as below:

VWR's Debt-to-EBITDA is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 1.8
* Ranked among companies with meaningful Debt-to-EBITDA only.

VWR Debt-to-EBITDA Historical Data

The historical data trend for VWR's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VWR Debt-to-EBITDA Chart

VWR Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Debt-to-EBITDA
Get a 7-Day Free Trial 9.27 8.29 3.94 4.35 4.54

VWR Quarterly Data
Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.35 4.99 4.75 4.85 4.23

Competitive Comparison of VWR's Debt-to-EBITDA

For the Diagnostics & Research subindustry, VWR's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


VWR's Debt-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, VWR's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where VWR's Debt-to-EBITDA falls into.



VWR Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

VWR's Debt-to-EBITDA for the fiscal year that ended in Dec. 2016 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(250.1 + 1766.9) / 444.1
=4.54

VWR's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2017 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(320.2 + 1859.8) / 516
=4.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2017) EBITDA data.


VWR  (NAS:VWR) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


VWR Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of VWR's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


VWR (VWR) Business Description

Traded in Other Exchanges
N/A
Address
VWR Corp operates in the healthcare sector based in the United States. It primarily offers laboratory products mainly in the American market, while distributing a minor share abroad. It provides a suite of products such as chemicals, reagents, consumables, durable products and scientific equipment and instruments to customers in the life science, general research and applied markets, including the biopharma, agricultural, chemical, environmental, food and beverage, healthcare, microelectronic, and petrochemical industries.
Executives
Madison Dearborn Partners Llc 10 percent owner THREE FIRST NATIONAL PLAZA, 70 WEST MADISON STREET, SUITE 4600, CHICAGO IL 60602
Gregory L Cowan officer: See remarks 1717 ARCH STREET, 35TH FLOOR, PHILADELPHIA PA 19103
Edward A Blechschmidt director ONE HEALTHSOUTH PARKWAY, BIRMINGHAM AL 35243
Douglas J. Pitts officer: See remarks 100 MATSONFORD ROAD, RADNOR PA 19087
Pamela Forbes Lieberman director 3400 N.WOLF ROAD, FRANKLIN PARK IL 60131
Robert Zollars director 3061 ZANKER RD, SAN JOSEC CA 95134
Timothy P Sullivan director, 10 percent owner THREE FIRST NATIONAL PLZ, SUITE 3800, CHICAGO IL 60602
Nicholas W Alexos director, 10 percent owner C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Kraemer Harry M Jansen Jr director DENTSPLY SIRONA INC., 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Madison Dearborn Partners V-a&c, L.p. 10 percent owner THREE FIRST NATIONAL PLAZA, SUITE 3800, CHICAGO IL 60602
Madison Dearborn Capital Partners V Executive-a L P 10 percent owner THREE FIRST NATIONAL PLAZA, SUITE 3800, CHICAGO IL 60602
Madison Dearborn Capital Partners V - C L P 10 percent owner THREE FIRST NATIONAL PLAZA, SUITE 3800, CHICAGO IL 60602
Madison Dearborn Capital Partners V - A L P 10 percent owner THREE FIRST NATIONAL PLAZA, SUITE 4600, CHICAGO IL 60602
Samuel M Mencoff 10 percent owner BUCKEYE TECHNOLOGIES INC, 1001 TILLMAN STREET, MEMPHIS TN 38112
Paul J Finnegan 10 percent owner PO BOX 2000, 3905 DAKOTA STREET SW, ALEXANDRIA MN 56308

VWR (VWR) Headlines

From GuruFocus

Largest Insiders' Trades of the Week

By Tiziano Frateschi Tiziano Frateschi 05-27-2016

Robert Olstein's Largest Sales of the 4th Quarter

By Tiziano Frateschi Tiziano Frateschi 02-09-2018